The spiralling cost of drugs presents an unavoidable challenge. It is the sort of warning liable to give health ministers sleepless nights. Professor Karol Sikora, the director of a private provider of cancer services, has warned that the National Health Service's bill for cancer drugs could rise to as much as £50bn, swallowing up half of the entire present health budget. The consequences would indeed, as Professor Sikora argues, push the NHS towards "meltdown".
Additional Story
Additional Story
0 comments:
Post a Comment